Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib [6] (multiple letters)

American Journal of Gastroenterology

Volumn 97, Issue 12, 2002, Pages 3209-3210

  Gornet, Jean Marc ^a   Hassani, Zahir ^a   Modigliani, Robert ^a   Lémann, Marc ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AZATHIOPRINE; CYCLOOXYGENASE 2 INHIBITOR; HEMOGLOBIN; HYDROXYCHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PREDNISONE; ROFECOXIB;

ADULT; BLOOD PRESSURE; CASE REPORT; CLINICAL TRIAL; COLON HEMORRHAGE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DRUG USE; ELECTROCOAGULATION; ENDOSCOPY; FEMALE; GASTROINTESTINAL TOXICITY; HEMATOCHEZIA; HEMOSTASIS; HUMAN; LETTER; MALAISE; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECTUM HEMORRHAGE;

EID: 0036895060     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)05561-2     Document Type: Letter

References (6)

1. Emery P, Zeidler H, Kvien TK, et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomised double-blind comparison. Lancet 1999;354:2106-11.
2. Reuter BK, Asfaha S, Buret A, et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclo-oxygenase-2. J Clin Invest 1996;98:2076-85.
3. Evans JM, McMahon AD, Murray FE, et al. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis sue to inflammatory bowel disease. Gut 1997;40:619-22.
4. Whittle BJR. COX-1 and COX-2 products in the gut: Therapeutic impact of COX-2 inhibitors. Gut 2000;47:320-5.
5. Kankuri E, Vaali K, Korpela R, et al. Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. Inflammation 2001;25:301-10.
6. Singer II, Kawka DW, Schloemann S, et al. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 1998;15:297-306.